KIF23 Antibody (Center) Blocking Peptide
Synthetic peptide
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Primary Accession | Q02241 |
---|---|
Clone Names | 100525274 |
Gene ID | 9493 |
---|---|
Other Names | Kinesin-like protein KIF23, Kinesin-like protein 5, Mitotic kinesin-like protein 1, KIF23, KNSL5, MKLP1 |
Format | Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed. |
Storage | Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C. |
Precautions | This product is for research use only. Not for use in diagnostic or therapeutic procedures. |
Name | KIF23 |
---|---|
Synonyms | KNSL5, MKLP1 |
Function | Component of the centralspindlin complex that serves as a microtubule-dependent and Rho-mediated signaling required for the myosin contractile ring formation during the cell cycle cytokinesis. Essential for cytokinesis in Rho-mediated signaling. Required for the localization of ECT2 to the central spindle. Plus-end-directed motor enzyme that moves antiparallel microtubules in vitro. |
Cellular Location | Nucleus. Cytoplasm, cytoskeleton, spindle. Midbody, Midbody ring. Note=Localizes to the interzone of mitotic spindles. Detected at the midbody during later stages of mitotic cytokinesis |
Tissue Location | Widely expressed.. |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
The protein encoded by this gene is a member ofkinesin-like protein family. This family includesmicrotubule-dependent molecular motors that transport organelleswithin cells and move chromosomes during cell division. Thisprotein has been shown to cross-bridge antiparallel microtubulesand drive microtubule movement in vitro. Alternate splicing of thisgene results in two transcript variants encoding two differentisoforms.
References
Olson, J.E., et al. Breast Cancer Res. Treat. (2010) In press :Douglas, M.E., et al. Curr. Biol. 20(10):927-933(2010)Seguin, L., et al. Mol. Cell. Biol. 29(2):570-581(2009)Pohl, C., et al. Cell 132(5):832-845(2008)Ewing, R.M., et al. Mol. Syst. Biol. 3, 89 (2007) :
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.